← Open Payments lookup

ANNA KIELAK: Open Payments

NPI 1952750671 · POULSBO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,415 in 68 payments from 16 companies in 2025. Trend: 2023 $1,589 · 2024 $1,810 · 2025 $1,415

Food & beverage: $1,415
CompanyPaymentsAmount
ABBVIE INC.18$357
Alkermes, Inc.10$193
Takeda Pharmaceuticals U.S.A., Inc.7$164
Otsuka America Pharmaceutical, Inc.9$153
E.R. Squibb & Sons, L.L.C.5$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Janssen Pharmaceuticals, Inc3$67
Neurocrine BioSciences, Inc.3$57
Tris Pharma Inc2$43
Teva Pharmaceuticals USA, Inc.2$39

Products named: VRAYLAR, REXULTI, TRINTELLIX, LYBALVI, COBENFY, CAPLYTA, SPRAVATO, INGREZZA.

Industry payments across WA — which companies pay providers there.